A brain plaque inhibitor developed by Merck is now being tested in larger studies for efficacy against the still unstoppable neurodegenerative disease
Metformin may slow or reverse dementia and cognitive impairment, even in nondiabetics
In precision medicine era legacy gifts of patient brain tissue reveal disease mechanisms and new therapeutic approaches
New findings underscore the challenge of balancing psychiatric needs and potential negative consequences for newborns
After decades of disappointment there is a new flurry of vaccine activity
Scientists have already started testing the treatment in humans
The go-to stroke drug often fails. Now doctors can slide out brain clots with wires and have new tools for other blockages
The agency faced a fierce backlash from users who call the plant a safer alternative to opioid painkillers
Resilient fungi survived Chernobyl, was sent into space and is now being studied in California
The “legal high” plant has been used to self-treat opioid withdrawal, pain and anxiety
Jean-Pierre Sauvage, James Fraser Stoddart and Bernard L. Feringa share the 2016 Nobel Prize in Chemistry for the design and synthesis of molecular machines.
As nonalcoholic steatohepatitis, or NASH, stealthily becomes a leading cause of transplants, drug companies race to develop treatments
The Nobel Prize in Physiology or Medicine was awarded today to Yoshinori Ohsumi of Japan for his discoveries concerning autophagy. Following the announcement, journalist Lotta Fredholm spoke to Juleen Zierath, chair of the Nobel Committee for Physiology or Medicine, about the research.
Yoshinori Ohsumi of Japan receives the 2016 Nobel Prize for pioneering work on autophagy
Japan's Yoshinori Ohsumi wins the 2016 prize for discoveries related to autophagy, the process in cells whereby they degrade some of their internal structures and send the parts out for recycling.
Despite new findings, certain advice still holds true
Compounds from the Southeast Asian tree offer hope for a safer opioid alternative, but research could slow to a crawl as the DEA steps in
A cluster of cases in Hawaii show signs of resistance to the two drugs used to treat it
Dianne Newman, who studies both geology and medicine, says she is a “pied piper” of microbes
Antibiotic resistance has grown so dire that it will be the subject of a dedicated global summit later this month